A critical evaluation of the methodology of the literature on medication compliance

被引:92
作者
Nichol, MB [1 ]
Venturini, F [1 ]
Sung, JCY [1 ]
机构
[1] Univ So Calif, Sch Pharm, Dept Pharmaceut Econ & Policy, Los Angeles, CA 90033 USA
关键词
methodology; compliance;
D O I
10.1345/aph.18233
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: To develop a simple evaluation tool to assess methodologic rigor of the literature on patient compliance with medications, and to apply the tool to a sample of the literature. METHODS: A computerized search of the MEDLINE database (January 1980-December 1996) was performed. All English-language articles on compliance with medications were identified, using the MeSH terms patient-compliance and drug-therapy. A 10% sample was then randomly selected for review, Methodologic rigor was assessed on eight standards: study design, specification of patient sample, power analysis, specification of disease, specification of therapeutic regimen, duration of follow-up, definition of compliance, and compliance measurement. The raw scores of the eight standards were then combined in three summary scores, standardized from 0 to 100: study design, disease-related features, and compliance issues. RESULTS: Seventy-two articles from 719 identified were reviewed. The majority of the research articles were descriptive (63.9%), and patients in these studies were selected mainly from a convenience sample (41.7%). Just nine studies were multicenter studies, and three employed power analysis. The compliance definition was replicable in 41.7% of the studies. In 22 articles neither the compliance measure nor the criteria were stated. One-quarter of the studies (18) used a nonvalidated measure of compliance. Only two studies reached a score of 6 in the compliance measure, and eight studies used two different measures of compliance simultaneously. The median values in the summary scores were: study design 8.3, disease 42.9, compliance issues 50. CONCLUSIONS: The quality of the compliance research was generally poor. These low scores reflect very important shortcomings in the methodology, Such oversights make it difficult for the reader to critically assess the validity of the conclusions.
引用
收藏
页码:531 / 540
页数:10
相关论文
共 81 条
[1]  
Andrewes D A, 1981, J R Coll Gen Pract, V31, P274
[3]   POLYMEDICATION AND MEDICATION COMPLIANCE IN PATIENTS WITH CHRONIC NONMALIGNANT PAIN [J].
BERNDT, S ;
MAIER, C ;
SCHUTZ, HW .
PAIN, 1993, 52 (03) :331-339
[4]   COMPLIANCE TO TREATMENT FOR HYPERTENSION IN ELDERLY PATIENTS - THE SHEP PILOT-STUDY [J].
BLACK, DM ;
BRAND, RJ ;
GREENLICK, M ;
HUGHES, G ;
SMITH, J .
JOURNALS OF GERONTOLOGY, 1987, 42 (05) :552-557
[5]   HYPOURICEMIC EFFECT OF ZUCLOPENTHIXOL - A POTENTIAL MARKER OF DRUG COMPLIANCE [J].
BLOCH, M ;
GUR, E ;
SHALEV, AY .
PSYCHOPHARMACOLOGY, 1992, 109 (03) :377-378
[6]  
BROERS B, 1994, ARCH INTERN MED, V154, P1121, DOI 10.1001/archinte.154.10.1121
[7]   COMPLIANCE WITH DOXYCYCLINE THERAPY FOR OUTPATIENT TREATMENT OF PELVIC INFLAMMATORY DISEASE [J].
BROOKOFF, D .
SOUTHERN MEDICAL JOURNAL, 1994, 87 (11) :1088-1091
[9]   AN EVALUATION OF A NEW PATIENT COMPLIANCE INDEX USING PLASMA PROPRANOLOL LEVELS [J].
CALDWELL, JR ;
FRADE, PD ;
REDDY, PJ ;
MAYER, JH ;
KELLY, AR .
JOURNAL OF CHRONIC DISEASES, 1984, 37 (9-10) :689-698
[10]  
CAMPBELL DT, 1963, EXPT QUASIEXPT DESIG